Microcephaly with or without short stature
MONDO:0100346Primary microcephaly refers to the clinical finding of a head circumference more than than 3 standard deviations (SD) below the age- and sex-related mean, present at birth. Primary microcephaly is a static developmental anomaly, distinguished from secondary microcephaly, which refers to a progressive neurodegenerative condition. Microcephaly is a disorder of fetal brain growth; individuals with microcephaly have small brains and almost always have intellectual disability, although rare individuals with mild microcephaly (-3 SD) and normal intelligence have been reported. Additional clinical features may include short stature or mild seizures. These clinical features include Seckel syndrome, a rare autosomal recessive disorder characterized by intrauterine growth retardation, dwarfism, microcephaly with intellectual disability.
8 clinical trials for this condition and its sub-types, 0 tagged with Microcephaly with or without short stature itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Microcephaly with or without short stature
-
Microcephaly 6 with or without short stature 0 trials · 8 incl. sub-types
2 sub-types
- Microcephaly 6, primary, autosomal recessive 8 trials
- Seckel syndrome 4 0 trials
-
Could a web course tame insomnia for home ventilator users?
Symptom relief CompletedThis study tests whether a web-based training program helps people with COPD who use a noninvasive ventilator (NIV) at home stick to their therapy and sleep better. Participants receive online lessons on using the device, and researchers measure their compliance and insomnia seve…
Sponsor: KTO Karatay University • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
Personalized sleep apnea treatment on the horizon?
Knowledge-focused CompletedThis study investigates why people develop obstructive sleep apnea (OSA) and whether the underlying cause affects how they respond to different treatments. Researchers will test three approaches—CPAP, a sleep medication (eszopiclone), and supplemental oxygen—in adults with OSA. T…
Phase 2 • Sponsor: University of California, San Diego • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC